-
1.发明申请公开(公告)号：US20170333535A1
公开(公告)日：2017-11-23
申请号：US15669340
申请日：2017-08-04
申请人： PFIZER INC.
发明人： KEITH A. JOHNSON , JASON C. ROUSE , PENELOPE JANE SHARPE , MICHAEL SHAMASHKIN , WENDY CAROL PIACENZA , MARY BETH SWITZER , STACEY B. WESTON , Michael Anthony JANKOWSKI
摘要： Compositions are provided comprising recombinant variants of the human clotting Factor Xa. Such compositions include a wide variety of isoforms and post-translational modifications of FXa and are useful for treating subjects in need of hemostasis.
-
2.发明申请公开(公告)号：US20210106658A1
公开(公告)日：2021-04-15
申请号：US16882598
申请日：2020-05-25
申请人： PFIZER INC.
发明人： KEITH A. JOHNSON , JASON C. ROUSE , PENELOPE JANE SHARPE , MICHAEL SHAMASHKIN , WENDY CAROL PIACENZA , MARY BETH SWITZER , STACEY B. WESTON , Michael Anthony JANKOWSKI
摘要： Compositions are provided comprising recombinant variants of the human clotting Factor Xa. Such compositions include a wide variety of isoforms and post-translational modifications of FXa and are useful for treating subjects in need of hemostasis.
-
3.发明申请COMPOSITIONS COMPRISING HETEROGENEOUS POPULATIONS OF RECOMBINANT HUMAN CLOTTING FACTOR XA PROTEINS 审中-公开包含重组人类衣原体XA蛋白异构体人群的组合物公开(公告)号：US20150182604A1
公开(公告)日：2015-07-02
申请号：US14495478
申请日：2014-09-24
申请人： PFIZER INC.
发明人： KEITH A. JOHNSON , JASON C. ROUSE , PENELOPE JANE SHARPE , MICHAEL SHAMASHKIN , WENDY CAROL PIACENZA , MARY BETH SWITZER , STACEY B. WESTON , Michael Anthony JANKOWSKI
CPC分类号： A61K38/4846 , A61K38/36 , C12N9/6432
摘要： Compositions are provided comprising recombinant variants of the human clotting Factor Xa. Such compositions include a wide variety of isoforms and post-translational modifications of FXa and are useful for treating subjects in need of hemostasis.
摘要翻译： 提供包含人凝血因子Xa的重组变体的组合物。 这样的组合物包括FXa的多种异构体和翻译后修饰，并且可用于治疗需要止血的受试者。
-
-
搜索结果
3 条记录 (耗时 0.011 秒)
